STAT3-mediated activation of myocardial capillary growth

Denise Hilfiker-Kleiner1, Anne Limbourg, Helmut Drexler

  • 1Department of Cardiology and Angiology, Medical School Hannover, Carl-Neuberg Strasse 1, 30625 Hannover, Germany. hilfiker.denise@mh-hannover.de

Insights

Signal transducer and activator of transcription 3 (STAT3) promotes cardiac angiogenesis and vessel formation in the adult heart. STAT3 also supports cardiomyocyte and endothelial cell survival, crucial for preventing heart failure.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Angiogenesis Research

Background:

  • Myocardial homeostasis relies on proper perfusion and vessel integrity.
  • Deficient oxygen supply due to impaired angiogenesis causes cardiomyocyte loss, fibrosis, and heart failure.

Purpose of the Study:

  • To review the role of signal transducer and activator of transcription 3 (STAT3) in regulating cardiac angiogenesis.
  • To highlight STAT3's function in promoting vessel formation and cell survival in the heart.

Main Methods:

  • Review of existing literature on STAT3 signaling in cardiac angiogenesis.
  • Analysis of STAT3's regulation of proangiogenic and antiangiogenic factors.
  • Examination of STAT3's role in cardiomyocyte and endothelial cell survival pathways.

Main Results:

  • STAT3 regulates vascular endothelial growth factor (VEGF) expression and activity in the postnatal heart.
  • STAT3 suppresses antiangiogenic and profibrotic gene programs via autocrine and paracrine circuits.
  • STAT3 signaling is essential for cardiomyocyte and endothelial cell survival and promotes cytokine-mediated cardiac angiogenesis.

Conclusions:

  • Properly timed STAT3 expression and activation are critical for cardiac angiogenesis.
  • STAT3 controls paracrine and autocrine mechanisms regulating angiogenic circuits and cell survival pathways.
  • STAT3 is not required for endothelial progenitor cell differentiation.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...